Sunday, December 12, 2010 8:00:22 PM
AEZS .
will hold an R&D Review for investors and analysts on Tuesday, December 14, 2010 from 4 p.m. to 6 p.m. (EST) in the Park Avenue Room of the InterContinental New York Barclay Hotel in New York City.
Aeterna Zentaris' management will introduce the Company's robust pipeline, focused mainly on oncology, and will be available for further discussion. Detailed presentations of the Company's ongoing late-stage clinical programs will be made by the following distinguished key opinion leaders:
http://finance.yahoo.com/news/Aeterna-Zentaris-To-Hold-RD-prnews-3307259146.html?x=0
will hold an R&D Review for investors and analysts on Tuesday, December 14, 2010 from 4 p.m. to 6 p.m. (EST) in the Park Avenue Room of the InterContinental New York Barclay Hotel in New York City.
Aeterna Zentaris' management will introduce the Company's robust pipeline, focused mainly on oncology, and will be available for further discussion. Detailed presentations of the Company's ongoing late-stage clinical programs will be made by the following distinguished key opinion leaders:
http://finance.yahoo.com/news/Aeterna-Zentaris-To-Hold-RD-prnews-3307259146.html?x=0
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
